Interferon-gamma activates multiple pathways to regulate the expression of the genes for major histocompatibility class II I-A beta, tumor necrosis factor and complement component C3 in mouse macrophages

European Journal of Immunology
A CeladaR A Maki

Abstract

The purpose of this study was to obtain additional information on the mechanism by which interferon-gamma (IFN-gamma) is able to regulate gene expression in macrophages. The expression of the genes for class II histocompatibility I-A beta, tumor necrosis factor (TNF) and complement component C3 was assayed after treating bone marrow macrophages with IFN-gamma. Each gene displayed a characteristic pattern of regulation. First, the increase in the level of RNA for each gene followed different kinetics. The level of TNF RNA increased within 15 min after IFN-gamma treatment and reached a plateau after 4 h. In contrast, there was a lag of about 4 h before the level of I-A beta RNA began to rise and a plateau was not reached until 48 h after the IFN-gamma treatment began. C3 gene expression followed an intermediate time course between that for TNF and I-A beta. Second, the expression of I-A beta was inhibited when cells were treated with both IFN-gamma and cycloheximide, while the expression of TNF and C3 was not. Interestingly, the sensitivity to cycloheximide only lasted 30 min following the addition of IFN-gamma, after which cycloheximide had no effect on the expression of I-A beta. Third, lipopolysaccharide abolished the IFN-gamm...Continue Reading

References

Jan 1, 1989·European Journal of Immunology·A Celada, R A Maki
Nov 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·P V BastaJ P Ting
Dec 1, 1985·The Journal of Clinical Investigation·A CeladaR D Schreiber
May 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·J SancéauC Vaquero
Jul 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·M A BlanarR A Flavell
May 1, 1969·The Journal of Experimental Medicine·G B Mackaness
Mar 1, 1981·Molecular and Cellular Biology·M GroudineH Weintraub
Jul 1, 1984·The Journal of Experimental Medicine·A CeladaR D Schreiber
Dec 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·K WiebauerG Fey
Jan 1, 1987·Immunology Today·T A Hamilton, D O Adams

❮ Previous
Next ❯

Citations

Sep 1, 1994·Pharmacology & Therapeutics·Y Ohmori, T A Hamilton
Oct 1, 1989·Research in Immunology·P M Kaye, J M Blackwell
Jan 1, 1990·Progress in Growth Factor Research·G R GuyC S Peng
Jan 5, 2002·Experimental Gerontology·Carmen HerreroAntonio Celada
Dec 30, 1999·Microbes and Infection·J LloberasA Celada
Jan 1, 1991·Journal of Immunoassay·P H van der MeideA H Borman
Oct 1, 1990·Journal of Interferon Research·M KitauraS Muramatsu
Feb 22, 2001·The Journal of Clinical Investigation·C HerreroA Celada
Jan 24, 2014·Mediators of Inflammation·Miriam WeissIrina A Udalova
Feb 1, 1992·European Journal of Pediatrics·R S WeeningD Roos
Jan 1, 1995·Critical Reviews in Oral Biology and Medicine : an Official Publication of the American Association of Oral Biologists·S R Barnum
Aug 19, 2003·The Journal of Biological Chemistry·Rubén VicenteAntonio Felipe
Oct 13, 1995·The Journal of Biological Chemistry·F E BorràsA Celada
Apr 10, 2020·European Journal of Immunology·Lorena Valverde-EstrellaAntonio Celada
Dec 22, 1999·The Journal of Immunology : Official Journal of the American Association of Immunologists·A F ValledorA Celada
Aug 7, 2012·European Journal of Immunology·Neus SerratAntonio Celada
Aug 18, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·A VerschoorM C Carroll
Nov 22, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·J XausA Celada
Apr 22, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Carlos SebastiánAntonio Celada
May 4, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Cristina CasalsAntonio Celada
May 18, 2021·American Journal of Physiology. Renal Physiology·Sorena LoNirmala Parajuli
Jan 1, 1996·Clinical and Diagnostic Laboratory Immunology·T CollinsK E Sullivan
Dec 11, 1997·Infection and Immunity·J BarbicR D Shahin
Nov 1, 1993·Immunobiology·M E MielkeH Hahn

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Expert Reviews in Molecular Medicine
Wang-Dong XuDong-Qing Ye
European Heart Journal Cardiovascular Imaging
Vassilis I BarberisChristos P Christou
Zentralblatt Für Bakteriologie, Mikrobiologie, Und Hygiene. Series A, Medical Microbiology, Infectious Diseases, Virology, Parasitology
S EhlersH Hahn
© 2022 Meta ULC. All rights reserved